These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 6411492

  • 1. Modification of subunit interaction in membrane-bound acid beta-glucosidase from Gaucher disease.
    Maret A, Potier M, Salvayre R, Douste-Blazy L.
    FEBS Lett; 1983 Aug 22; 160(1-2):93-7. PubMed ID: 6411492
    [Abstract] [Full Text] [Related]

  • 2. In vitro detergent activation of lysosomal acid beta-glucosidase in the spleen of normal and type 1 Gaucher patients is not accompanied by change in aggregation state.
    Maret A, Potier M, Salvayre R, Troly M, Beauregard G, Douste-Blazy L.
    Biochim Biophys Acta; 1989 Jul 06; 996(3):254-6. PubMed ID: 2502183
    [Abstract] [Full Text] [Related]

  • 3. Gaucher disease (type 1): physical and kinetic properties of liposomal and soluble 'acid' beta-glucosidase.
    Carroll M.
    J Inherit Metab Dis; 1985 Jul 06; 8(1):33-7. PubMed ID: 3921758
    [Abstract] [Full Text] [Related]

  • 4. Isoenzymes of membrane-bound beta-glucosidase of human spleen.
    Yaqoob M, Carroll M.
    Biochem J; 1980 Feb 01; 185(2):541-3. PubMed ID: 6772153
    [Abstract] [Full Text] [Related]

  • 5. Physical and kinetic properties of beta-glucosidase in Gaucher disease.
    Karazeh A, Carroll M.
    J Inherit Metab Dis; 1983 Feb 01; 6(3):101-4. PubMed ID: 6422137
    [Abstract] [Full Text] [Related]

  • 6. [Properties of the molecular forms of beta-glucosidase and beta-glucocerebrosidase from normal human and Gaucher disease spleen (author's transl)].
    Maret A, Salvayre R, Negre A, Douste-Blazy L.
    Eur J Biochem; 1981 Apr 01; 115(3):455-61. PubMed ID: 6786882
    [No Abstract] [Full Text] [Related]

  • 7. Multiple forms of beta-glucosidase in Gaucher disease.
    Yaqoob M, Carroll M.
    Prog Clin Biol Res; 1982 Apr 01; 95():453-63. PubMed ID: 6812081
    [No Abstract] [Full Text] [Related]

  • 8. Comparative properties of the three groups of splenic beta-glucosidase molecular forms.
    Salvayre R, Maret A, Negre A, Douste-Blazy L.
    Prog Clin Biol Res; 1982 Apr 01; 95():443-52. PubMed ID: 6812080
    [No Abstract] [Full Text] [Related]

  • 9. Modifications of the molecular weight of membrane-bound nonspecific beta-glucosidase in type 1 Gaucher disease determined in situ by the radiation inactivation method.
    Maret A, Potier M, Salvayre R, Douste-Blazy L.
    Biochim Biophys Acta; 1984 May 25; 799(1):91-4. PubMed ID: 6232954
    [Abstract] [Full Text] [Related]

  • 10. Multiple forms of membrane-bound beta-glucosidase in Gaucher's disease.
    Yaqoob M, Carroll M.
    Clin Genet; 1981 Aug 25; 20(2):161-7. PubMed ID: 6796311
    [Abstract] [Full Text] [Related]

  • 11. Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.
    Gatt S, Dinur T, Osiecki K, Desnick RJ, Grabowski GA.
    Enzyme; 1985 Aug 25; 33(2):109-19. PubMed ID: 3924590
    [Abstract] [Full Text] [Related]

  • 12. Beta-glucosidase activity in liver, spleen and brain in acute neuropathic Gaucher disease.
    Takahashi T, Nishio H, Kodama S, Nakamura H.
    Brain Dev; 1990 Aug 25; 12(2):202-5. PubMed ID: 2113779
    [Abstract] [Full Text] [Related]

  • 13. Acid beta-glucosidase and the diagnosis of Gaucher's disease in liver and spleen.
    Butterworth J, Broadhead DM.
    Clin Chim Acta; 1978 Aug 01; 87(3):433-40. PubMed ID: 28186
    [Abstract] [Full Text] [Related]

  • 14. A study of acid beta-glucosidase in a patient with Gaucher disease and leukemia.
    Leibovitz-BenGershon Z, Rosenthal J, Shinar E.
    Prog Clin Biol Res; 1982 Aug 01; 95():481-91. PubMed ID: 6812083
    [No Abstract] [Full Text] [Related]

  • 15. The beta-glucosidase isozymes and the enzymatic defect in Gaucher disease.
    Patrick AD.
    Prog Clin Biol Res; 1982 Aug 01; 95():287-308. PubMed ID: 6812075
    [No Abstract] [Full Text] [Related]

  • 16. Gaucher's disease II. Studies on the kinetics of beta-glucosidase and the effects of sodium taurocholate in normal and Gaucher tissues.
    Choy FY, Davidson RG.
    Pediatr Res; 1980 Jan 01; 14(1):54-9. PubMed ID: 6767218
    [Abstract] [Full Text] [Related]

  • 17. In utero diagnosis of Gaucher disease.
    Kitagawa T, Owada M, Sakiyama T, Aoki K, Kamoshita S, Amenomori Y, Kobayashi T.
    Am J Hum Genet; 1978 May 01; 30(3):322-7. PubMed ID: 98040
    [Abstract] [Full Text] [Related]

  • 18. Qualitative characteristics of the beta-glucosidase isozymes.
    Choy FY, Davidson RG.
    Prog Clin Biol Res; 1982 May 01; 95():415-41. PubMed ID: 6812079
    [No Abstract] [Full Text] [Related]

  • 19. Human acid beta-glucosidase. Use of conduritol B epoxide derivatives to investigate the catalytically active normal and Gaucher disease enzymes.
    Grabowski GA, Osiecki-Newman K, Dinur T, Fabbro D, Legler G, Gatt S, Desnick RJ.
    J Biol Chem; 1986 Jun 25; 261(18):8263-9. PubMed ID: 3087971
    [Abstract] [Full Text] [Related]

  • 20. In situ radiation-inactivation size of fibroblast membrane-bound acid beta-glucosidase in Gaucher type 1, type 2 and type 3 disease.
    Choy FY, Woo M, Potier M.
    Biochim Biophys Acta; 1986 Mar 07; 870(1):76-81. PubMed ID: 3947649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.